3,4-dihydroxyphenylacetic acid has been researched along with 2,3-dihydroxybenzoic acid in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Günzler, V; Hanauske-Abel, HM; Kivirikko, KI; Majamaa, K; Myllylä, R | 1 |
| Bora-Tatar, G; Dalkara, S; Dayangaç-Erden, D; Demir, AS; Erdem-Yurter, H; Yelekçi, K | 1 |
| Baeza, J; Durán, N; Freer, J; Parra, C; Rodriguez, J | 1 |
| Cann-Moisan, C; Caroff, J; Duine, JM; Floch, F; Mialon, P | 1 |
| Abin, JA; Costa, G; Dajas, F; Dajas-Bailador, FA; Martignoni, E; Martinez-Borges, A; Nappi, G | 1 |
| Bringmann, G; Feineis, D; Gerlach, M; God, R; Heim, C; Lan, J; Riederer, P; Sontag, KH; Xiao, AY | 1 |
| Hindmarsh, JG; Jenner, P; Rose, S | 1 |
| Gerlach, M; Heim, C; Kurz, T; Lan, J; Riederer, P; Sieklucka, M; Sontag, KH; Zhang, J | 1 |
| Mohanakumar, KP; Muralikrishnan, D; Thomas, B | 1 |
| Kita, T; Kubo, K; Matsunari, Y; Nakashima, T; O'Hara, K; Saraya, T; Shimada, K; Wagner, GC | 1 |
| Chen, YK; Lin, HC; Liu, JC; Wan, FJ | 1 |
| Aloisi, G; Battaglia, G; Busceti, CL; Cerrito, F; De Blasi, A; Fornai, F; Melchiorri, D; Nicoletti, F | 1 |
| Groce, SL; Lipscomb, JD | 1 |
| Ebinger, G; Michotte, Y; Sarre, S; Yuan, H | 1 |
| Aoki, R; Asakura, T; Ezcurra, M; Goshima, Y; Ibi, M; Iino, Y; Kajihara, Y; Kanai, Y; Misu, Y; Miyamae, T; Mori, I; Nakamura, F; Ogura, K; Sasakura, H; Schafer, WR; Yagami, T | 1 |
15 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 2,3-dihydroxybenzoic acid
| Article | Year |
|---|---|
Partial identity of the 2-oxoglutarate and ascorbate binding sites of prolyl 4-hydroxylase.
Topics: Animals; Ascorbic Acid; Binding Sites; Chick Embryo; Ketoglutaric Acids; Kinetics; Phenols; Procollagen-Proline Dioxygenase; Protein Binding; Structure-Activity Relationship; Substrate Specificity | 1986 |
Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.
Topics: Caffeic Acids; Carboxylic Acids; Catalytic Domain; Chlorogenic Acid; Curcumin; Enzyme Inhibitors; HeLa Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Models, Molecular; Molecular Structure; Protein Binding | 2009 |
Iron-binding catechols oxidating lignin and chlorolignin.
Topics: 3,4-Dihydroxyphenylacetic Acid; Dioxanes; Hydroxybenzoates; Iron; Iron Chelating Agents; Kinetics; Lignin; Oxidation-Reduction; Spectrometry, Fluorescence; Spectrophotometry | 1998 |
Simultaneous measurement of monoamines, their metabolites and 2,3- and 2,5-dihydroxybenzoates by high-performance liquid chromatography with electrochemical detection. Application to rat brain dialysates.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Corpus Striatum; Dopamine; Gentisates; Homovanillic Acid; Hydroxybenzoates; Hydroxyindoleacetic Acid; Hydroxyl Radical; Methoxyhydroxyphenylglycol; Norepinephrine; Oxygen; Rats; Restraint, Physical; Serotonin | 1998 |
Hydroxyl radical production in the substantia nigra after 6-hydroxydopamine and hypoxia-reoxygenation.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Hydroxybenzoates; Hydroxyl Radical; Hydroxylation; Hypoxia, Brain; Male; Neurotoxins; Oxidopamine; Oxygen; Partial Pressure; Rats; Rats, Sprague-Dawley; Salicylic Acid; Substantia Nigra | 1998 |
1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline increases extracellular serotonin and stimulates hydroxyl radical production in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aspartic Acid; Carbolines; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Extracellular Space; gamma-Aminobutyric Acid; Glutamic Acid; Homovanillic Acid; Hydroxybenzoates; Hydroxyindoleacetic Acid; Hydroxyl Radical; Male; Microdialysis; Rats; Rats, Wistar; Serotonin | 1998 |
Neuronal nitric oxide synthase inhibition reduces MPP+-evoked hydroxyl radical formation but not dopamine efflux in rat striatum.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydroxybenzoates; Hydroxyl Radical; In Vitro Techniques; Indazoles; Male; Microdialysis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats; Rats, Wistar | 1999 |
Cerebral oligaemia episode triggers free radical formation and late cognitive deficiencies.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aspartic Acid; Carotid Stenosis; Cognition Disorders; Corpus Striatum; Disease Models, Animal; Dopamine; Escape Reaction; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Homovanillic Acid; Hydroxybenzoates; Hydroxyl Radical; Ischemic Attack, Transient; Learning Disabilities; Male; Maze Learning; Memory Disorders; Microdialysis; Oxidative Stress; Psychomotor Performance; Rats; Rats, Wistar; Reaction Time; Reperfusion Injury; Spatial Behavior; Swimming; Time Factors | 2000 |
Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Catalepsy; Cyclooxygenase Inhibitors; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Free Radical Scavengers; Gentisates; Glutathione; Homovanillic Acid; Hydroxybenzoates; Hydroxyl Radical; Male; Mice; Mice, Inbred BALB C; Monoamine Oxidase; MPTP Poisoning; Neostriatum; Neuroprotective Agents; Sodium Salicylate; Substantia Nigra | 2000 |
Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB/c mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine-Related Disorders; Animals; Behavior, Animal; Body Temperature; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Homovanillic Acid; Hydroxybenzoates; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Methamphetamine; Mice; Mice, Inbred BALB C; Neurotoxicity Syndromes; Salicylic Acid; Self-Injurious Behavior; Species Specificity | 2000 |
Potent, hydroxyl radical-scavenging effect of apomorphine with iron and dopamine perfusion in rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Corpus Striatum; Dopamine; Dopamine Agonists; Free Radical Scavengers; Hydroxybenzoates; Hydroxyl Radical; Iron; Male; Microdialysis; Rats; Rats, Sprague-Dawley | 2001 |
Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Temperature; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Excitatory Amino Acid Antagonists; Fever; Glial Fibrillary Acidic Protein; Homovanillic Acid; Hydroxybenzoates; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Mice, Inbred C57BL; Microdialysis; Nerve Tissue Proteins; Pyridines; Reactive Oxygen Species; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Tyrosine 3-Monooxygenase | 2002 |
Conversion of extradiol aromatic ring-cleaving homoprotocatechuate 2,3-dioxygenase into an intradiol cleaving enzyme.
Topics: 3,4-Dihydroxyphenylacetic Acid; Brevibacterium; Dioxygenases; Hydroxybenzoates; Mutagenesis, Site-Directed; Nuclear Magnetic Resonance, Biomolecular; Oxygenases; Spectrophotometry; Structure-Activity Relationship | 2003 |
Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Behavior, Animal; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis; Disease Models, Animal; Dopamine; Drug Interactions; Electrochemistry; Hydroxybenzoates; Immunohistochemistry; Male; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Psychomotor Performance; Rats; Rats, Wistar; Stereotyped Behavior; Time Factors; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2004 |
A seven-transmembrane receptor that mediates avoidance response to dihydrocaffeic acid, a water-soluble repellent in Caenorhabditis elegans.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Animals, Genetically Modified; Behavior, Animal; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Caffeic Acids; Catechols; Cloning, Molecular; Dose-Response Relationship, Drug; Escape Reaction; Hydroxybenzoates; Larva; Luminescent Proteins; Membrane Potentials; Microinjections; Models, Molecular; Mutation; Receptors, G-Protein-Coupled; Sensory Receptor Cells; Xenopus | 2011 |